-AFP Bayer AG said, on Tuesday, it was mulling ways to challenge a ground-breaking Indian ruling allowing a local firm to produce a vastly cheaper copy of a cancer drug made by the German pharmaceutical giant. The ruling on Monday by India's Controller-General of Patents marked the first time a so-called ‘compulsory licence' for production of a patented drug has been granted in India, known as a global generics drug powerhouse. Evaluating options “We...

The government's decision to bust the price as well as monopoly of Bayer's anti-cancer drug, through the process of compulsory licensing now opens up the field for the generic industry to follow suit and could well pave the way for the availability of cheaper drugs for lifestyle diseases.  More generic companies could invoke the compulsory licensing clause of the Indian Patents Act, following Monday's decision to allow Natco Pharma to sell...

-The Telegraph Bengal’s co-operation department spent the better part of Tuesday on an unusual mission: how to enforce Mamata Banerjee’s very chief ministerial order to nail those who tried to recover money lent by a co-operative bank. “I have asked to lodge an FIR,” Mamata had declared yesterday while ordering the withdrawal of attachment notices on two farmers and announcing that the law will be changed to make government approval mandatory before...

Madhya Pradesh chief minister Shivraj Singh Chauhan today ordered a CBI investigation into last week’s murder of IPS officer Narendra Kumar, allegedly by mining mafia. Chauhan said he was responding to an appeal by Madhurani, the slain officer’s widow who is an IAS officer in the state, and not clamours from the Congress. The Opposition party has been demanding a probe by the agency and called a bandh today to protest the...

In a landmark decision, India’s intellectual property office on Monday allowed Hyderabad-based Natco Pharma Ltd to make and sell a copycat version of German drug maker Bayer AG’s patented cancer treatment Nexavar. It’s the first time that an Indian company has been granted the so-called compulsory licence to market a generic version of a patented drug. The drug, patented by Bayer in India in 2008, is used in the treatment of...